openPR Logo
Press release

Rising incidences of Alzheimer’s is expected to foster the growth of Advanced Therapy Medicinal Products market By Top Key Players like Uniqure, Pfizer, Bluebird Bio Inc., BioMarin Pharmaceutical, Novartis AG

11-28-2018 02:46 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products (ATMPs) are innovative therapies that comprises cell therapy, gene therapy, and tissue engineered products. Cell therapy products include cellular immunotherapies and autologous and allogeneic cells for certain therapeutic indications including adult and embryonic stem cells. Whereas, Human gene therapy refers to products that introduce genetic material into individuals DNA to replace faulty or missing genetic material, thus treating a disease or abnormal medical condition. These are a novel class of medicines that offer potential treatment opportunities for diseases that have currently limited or no therapeutic options such as hemophilia, cystic fibrosis, metabolic disorders, muscular dystrophies, skin burns, Alzheimer, and cancer.

Request Sample Copy Of This Business Report:
www.coherentmarketinsights.com/insight/request-sample/1101

Rising incidences of Alzheimer’s is expected to foster the growth of advanced therapy medicinal products market

The factors that are contributing the growth of advanced therapy medicinal products market are rising prevalence of Alzheimer’s disease. According to Alzheimer’s disease International in 2017, around 50 million people were estimated to suffer from Alzheimer’s disease across the globe. Furthermore, rising demand for gene therapies used in the treatment of ocular, neurodegenerative diseases, and several cancers accompanied by technological advancements in genetic engineering tool such as RNAi are the factors that are expected to boost the growth of advanced therapy medicinal products market. However, the factors that are hindering the growth of advanced medicinal therapy products market are inadequate transparency, lack of funds, and regulatory guidance for biopharmaceutical companies to manufacture these therapies and products.

Advanced therapy medicinal products are segmented on the basis of therapy, diseases, and geography

On the basis of products, the global advanced therapy medicinal products market are segmented into:

Somatic Cell Therapy Medicinal Products
Tissue Engineered Medicinal Products
Gene Therapy Medicinal Products

The key players operating the advanced therapy medicinal products market include Uniqure, Pfizer, Bluebird Bio Inc., BioMarin Pharmaceutical, Novartis AG, GE Healthcare, Shire Biotechnology, and Kite Pharma. The key players are focusing on strategic mergers and acquisition and development of innovative products.

Download the PDF brochure:
www.coherentmarketinsights.com/insight/request-pdf/1101

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising incidences of Alzheimer’s is expected to foster the growth of Advanced Therapy Medicinal Products market By Top Key Players like Uniqure, Pfizer, Bluebird Bio Inc., BioMarin Pharmaceutical, Novartis AG here

News-ID: 1405525 • Views:

More Releases from Coherent Market Insights - Biotechnology

Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 Period till 2027 | Medtronic Plc, Hill-Rom Holdings, iRhythm Technologies
Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027." Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast Period 2017 - 2025 And The Top Competitors Are Crown Bioscience, ProSpec Tany TechnoGene, BPS Bioscience, Sigma Aldrich Company, Novoprotein Scientific
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players Biocon, Pfizer Inc., F. Hoffmann-La Roche Ltd, Amgen Inc., Kyowa Pharmaceutical Industry Co. Ltd, Boehringer Ingelheim GmbH, AstraZeneca, Novartis AG, and Merck & Co
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., Bard1 Life Sciences Limited, Bio-Rad Laboratories, Abbott Laboratories, Becton, Dickinson and Company, Merck & Co., Inc., Qiagen N.V., and Thermo Fisher Scientific Inc
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy

All 5 Releases


More Releases for Medicinal

Medicinal Fungi Market 2022 | Detailed Report
The Medicinal Fungi market study is an in-depth analysis covering several elements critical to the growth and dynamics of the market. The important facts and data provided in the Medicinal Fungi market study for the estimated forecast period. It also, serve as a useful resource for consumers seeking guidance in making decisions to strengthen their current market position or enter the industry. The global Medicinal Fungi market is segmented into
Changing Purchasing Patterns Of Consumers Towards Medicinal Food Is Likely To Bo …
Medicinal mushrooms are mushrooms that are grown for their high nutritional profile of antioxidants, proteins, amino acids, and vitamins. Medicinal mushrooms are native to Asia and are grown there on a large scale. Medicinal mushrooms are known for their remedies for colds, seasonal allergies, relief from asthma and bronchitis, inflammation, and for improving nervous system function. As consumers become more interested in health food products, particularly in Europe and North America,
Virtual reality to replace medicinal painkillers
Virtual Reality (VR) technology may be a pathway to minimize chronic pain. The USA is facing its worst ever drug epidemic with more than 16, 000 deaths recorded in 2015, mainly due to opioid overdoses. US researchers are now exploring VR as an alternative solution to minimize pain. In a trial group, VR medical therapies helped reduce pain by 60–75% after 60 sessions. Can VR technology provide an alternative to addictive pain
Global Summit on Medicinal Chemistry 2018
On behalf of Medicinal Chemistry 2018 Organizing Committee, we are pleased to invite Chairperson, Director/ Dean, Associate Professors, professors, PhD students and post graduates of Chemistry, Pharmaceuticals, Biology and Physical Sciences, Chemical Biology, Analytical Chemistry, Nano Science, and related fields., Teachers, Business delegates and Young researchers across the world to attend Global Summit on Medicinal Chemistry which is to be held on July 30-31, 2018 at Amsterdam, Netherlands. The conference
Global Summit on Medicinal Chemistry 2018
On behalf of Medicinal Chemistry 2018 Organizing Committee, we are pleased to invite Chairperson, Director/ Dean, Associate Professors, professors, PhD students and post graduates of Chemistry, Pharmaceuticals, Biology and Physical Sciences, Chemical Biology, Analytical Chemistry, Nano Science, and related fields., Teachers, Business delegates and Young researchers across the world to attend Global Summit on Medicinal Chemistry which is to be held on July 30-31, 2018 at Amsterdam, Netherlands. The conference
Medicinal Cannabis Market
Medicinal cannabis , also known as medicinal marijuana, is used either to treat disease or improve symptoms. Cannabis has been considered to be a major source of drug addiction. Extract from the dried flower bud part of the plant called as Marijuana has certain medicinal properties. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are being used in treatment of certain disease or health conditions such as pain, blood